Intrauterine Contraceptive Devices Market (IUD/IUCD),by Type [Hormonal IUCD, Copper IUCD] – Global Forecast to 2019
The global intrauterine contraceptive devices market is estimated to grow at a CAGR of 6.8% from 2014 to 2019. The growth of the intrauterine contraceptive devices market is driven by factors such as increasing rate of unplanned pregnancies, effective contraception and less side effects of IUCD, implementation of Affordable Care Act (ACA), rising initiatives of private firms directed towards reducing the expenses related to abortion, funds/grants for IUCD products, and technological advancements. However, high cost of treatment, threat of causing pelvic inflammatory infection (PID), threat of causing ectopic pregnancy, high rate of complications during unplanned pregnancy, and need of compulsory assistance of medical professional is hampering the growth of IUCD market. Moreover, rising number of players in this segment, technological advancements are creating growth opportunities for the global intrauterine contraceptive devices market.
In this report, the market has been broadly classified on the basis of types which includes; Hormonal IUCD and Copper IUCD. The copper IUCD market segment is accounted for the largest market share of 51.9%.
Geographically, the market in Asia accounted for the largest share of 35.0% of the Global Intrauterine Contraceptive Devices market in 2014, followed by Europe. The Intrauterine Contraceptive Devices market in the U.S. is primarily driven by Affordable Care Act, technological advancements. However, stringent regulatory and reimbursement policies in U.S., threat to PID infection are hampering the growth of the Intrauterine Contraceptive Devices market in this region.
The global intrauterine contraceptive devices market is a competitive market with a number of market players. Bayer HealthCare AG (A subsidiary of BAYER AG) (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Actavis Plc. (Ireland), and Medicines360 (Ireland) are some of the major players operating in this market. New product launches and partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to strengthen their position in this market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—, market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging- and high-growth segments of the global intrauterine contraceptive devices market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
In this report, the market has been broadly classified on the basis of types which includes; Hormonal IUCD and Copper IUCD. The copper IUCD market segment is accounted for the largest market share of 51.9%.
Geographically, the market in Asia accounted for the largest share of 35.0% of the Global Intrauterine Contraceptive Devices market in 2014, followed by Europe. The Intrauterine Contraceptive Devices market in the U.S. is primarily driven by Affordable Care Act, technological advancements. However, stringent regulatory and reimbursement policies in U.S., threat to PID infection are hampering the growth of the Intrauterine Contraceptive Devices market in this region.
The global intrauterine contraceptive devices market is a competitive market with a number of market players. Bayer HealthCare AG (A subsidiary of BAYER AG) (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Actavis Plc. (Ireland), and Medicines360 (Ireland) are some of the major players operating in this market. New product launches and partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to strengthen their position in this market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—, market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging- and high-growth segments of the global intrauterine contraceptive devices market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on Intrauterine Contraceptive Devices offered by the top players in the Global Intrauterine Contraceptive Devices market
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the Global Intrauterine Contraceptive Devices market.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various Intrauterine Contraceptive Devices across geographies.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Global Intrauterine Contraceptive Devices market.
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the Global Intrauterine Contraceptive Devices market.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF INTRAUTERINE CONTRACEPTIVE DEVICES MARKET
2.2 ARRIVING AT THE GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET SIZE
2.2.1 TOP-DOWN APPROACH
2.2.2 BOTTOM-UP APPROACH
2.2.3 MACROINDICATOR-BASED APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 GAP ANALYSIS
4.3 MARKET DRIVERS AND INHIBITORS
4.4 KEY MARKET DYNAMICS
5 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
5.1 INTRODUCTION
5.1.1 COPPER IUD
5.1.2 HORMONAL IUD
5.2 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET SIZE, BY TYPE
5.3 GLOBAL HORMONAL IUCD MARKET, BY GEOGRAPHY
5.4 GLOBAL COPPER IUCD MARKET, BY GEOGRAPHY
6 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY
6.1 INTRODUCTION
6.2 ASIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET
6.2.1 CHINA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.2.2 REPUBLIC OF KOREA (ROK) INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.2.3 JAPAN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.2.4 INDIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.3 NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY
6.3.1 U.S. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.3.2 MEXICO INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.3.3 CANADA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.4 EUROPE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET
6.4.1 GERMANY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.4.2 FRANCE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.4.3 U.K. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.4.4 ITALY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.4.5 SPAIN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
7 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPETITIVE LANDSCAPE
7.1 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPANY SHARE ANALYSIS
7.2 MERGERS & ACQUISITIONS
7.3 NEW PRODUCT DEVELOPMENT
7.4 REGULATORY APPROVALS
7.5 PARTNERSHIP
7.6 COLLABORATIONS
8 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY COMPANY
(Overview, Financials, Products & Services, Strategy, and Developments)*
8.1 BAYER HEALTHCARE AG (SUBSIDIARY OF BAYER AG)
8.2 TEVA PHARMACEUTICAL INDUSTRIES LTD.
8.3 ACTAVIS PLC
8.4 MEDICINES360
8.5 TRIMEDIC SUPPLY NETWORK LTD.
8.6 MEDISAFE DISTRIBUTION INC.
8.7 BESINS HEALTHCARE (MONA LISA N.V) CANADA
8.8 SMB CORPORATION
8.9 OCON MEDICAL LTD.
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
9 APPENDIX
9.1 RELATED REPORTS
9.2 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
9.2.1 RT SNAPSHOTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF INTRAUTERINE CONTRACEPTIVE DEVICES MARKET
2.2 ARRIVING AT THE GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET SIZE
2.2.1 TOP-DOWN APPROACH
2.2.2 BOTTOM-UP APPROACH
2.2.3 MACROINDICATOR-BASED APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 GAP ANALYSIS
4.3 MARKET DRIVERS AND INHIBITORS
4.4 KEY MARKET DYNAMICS
5 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
5.1 INTRODUCTION
5.1.1 COPPER IUD
5.1.2 HORMONAL IUD
5.2 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET SIZE, BY TYPE
5.3 GLOBAL HORMONAL IUCD MARKET, BY GEOGRAPHY
5.4 GLOBAL COPPER IUCD MARKET, BY GEOGRAPHY
6 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY
6.1 INTRODUCTION
6.2 ASIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET
6.2.1 CHINA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.2.2 REPUBLIC OF KOREA (ROK) INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.2.3 JAPAN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.2.4 INDIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.3 NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY
6.3.1 U.S. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.3.2 MEXICO INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.3.3 CANADA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.4 EUROPE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET
6.4.1 GERMANY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.4.2 FRANCE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.4.3 U.K. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.4.4 ITALY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
6.4.5 SPAIN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE
7 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPETITIVE LANDSCAPE
7.1 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPANY SHARE ANALYSIS
7.2 MERGERS & ACQUISITIONS
7.3 NEW PRODUCT DEVELOPMENT
7.4 REGULATORY APPROVALS
7.5 PARTNERSHIP
7.6 COLLABORATIONS
8 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY COMPANY
(Overview, Financials, Products & Services, Strategy, and Developments)*
8.1 BAYER HEALTHCARE AG (SUBSIDIARY OF BAYER AG)
8.2 TEVA PHARMACEUTICAL INDUSTRIES LTD.
8.3 ACTAVIS PLC
8.4 MEDICINES360
8.5 TRIMEDIC SUPPLY NETWORK LTD.
8.6 MEDISAFE DISTRIBUTION INC.
8.7 BESINS HEALTHCARE (MONA LISA N.V) CANADA
8.8 SMB CORPORATION
8.9 OCON MEDICAL LTD.
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
9 APPENDIX
9.1 RELATED REPORTS
9.2 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
9.2.1 RT SNAPSHOTS
LIST OF TABLES
Table 1 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: DRIVERS AND INHIBITORS
Table 2 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 3 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
Table 4 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 5 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 6 GLOBAL HORMONAL IUD MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
Table 7 GLOBAL HORMONAL IUD MARKET, BY GEOGRAPHY, 2012-2019 (UNITS)
Table 8 GLOBAL COPPER IUD MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
Table 9 GLOBAL COPPER IUD MARKET, BY GEOGRAPHY, 2012-2019 (UNITS)
Table 10 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
Table 11 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2012-2019 (UNITS)
Table 12 ASIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
Table 13 ASIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2012-2019 (UNITS)
Table 14 CHINA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 15 CHINA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 16 CHINA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 17 CHINA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 18 REPUBLIC OF KOREA (ROK) INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 19 REPUBLIC OF KOREA (ROK) INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 20 REPUBLIC OF KOREA (ROK) INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 21 REPUBLIC OF KOREA (ROK) INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 22 JAPAN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 23 JAPAN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 24 JAPAN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 25 JAPAN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 26 INDIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 27 INDIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019, (UNITS)
Table 28 INDIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 29 INDIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 30 NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
Table 31 NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2012-2019 (UNITS)
Table 32 U.S. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 33 U.S. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 34 U.S. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 35 U.S. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 36 MEXICO INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 37 MEXICO INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 38 MEXICO INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 39 MEXICO INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 40 CANADA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 41 CANADA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 42 CANADA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 43 CANADA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 44 EUROPE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
Table 45 EUROPE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2012-2019 (UNITS)
Table 46 GERMANY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 47 GERMANY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 48 GERMANY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 49 GERMANY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 50 FRANCE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 51 FRANCE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 52 FRANCE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 53 FRANCE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 54 U.K. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 55 U.K. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 56 U.K. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 57 U.K. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 58 ITALY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 59 ITALY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 60 ITALY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 61 ITALY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 62 SPAIN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 63 SPAIN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 64 SPAIN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 65 SPAIN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 66 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Table 67 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: MERGERS & ACQUISITIONS
Table 68 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: REGULATORY APPROVALS
Table 69 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: PARTNERSHIP
Table 70 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COLLABORATIONS
Table 71 BAYER HEALTHCARE AG: KEY FINANCIALS, 2009-2014 (USD MN)
Table 72 TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY FINANCIALS, 2011-2014 (USD MN)
Table 73 ACTAVIS PLC: KEY FINANCIALS, 2012-2014 (USD MN)
Table 1 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: DRIVERS AND INHIBITORS
Table 2 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 3 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
Table 4 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 5 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 6 GLOBAL HORMONAL IUD MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
Table 7 GLOBAL HORMONAL IUD MARKET, BY GEOGRAPHY, 2012-2019 (UNITS)
Table 8 GLOBAL COPPER IUD MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
Table 9 GLOBAL COPPER IUD MARKET, BY GEOGRAPHY, 2012-2019 (UNITS)
Table 10 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
Table 11 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2012-2019 (UNITS)
Table 12 ASIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
Table 13 ASIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2012-2019 (UNITS)
Table 14 CHINA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 15 CHINA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 16 CHINA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 17 CHINA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 18 REPUBLIC OF KOREA (ROK) INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 19 REPUBLIC OF KOREA (ROK) INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 20 REPUBLIC OF KOREA (ROK) INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 21 REPUBLIC OF KOREA (ROK) INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 22 JAPAN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 23 JAPAN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 24 JAPAN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 25 JAPAN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 26 INDIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 27 INDIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019, (UNITS)
Table 28 INDIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 29 INDIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 30 NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
Table 31 NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2012-2019 (UNITS)
Table 32 U.S. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 33 U.S. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 34 U.S. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 35 U.S. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 36 MEXICO INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 37 MEXICO INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 38 MEXICO INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 39 MEXICO INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 40 CANADA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 41 CANADA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 42 CANADA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 43 CANADA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 44 EUROPE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
Table 45 EUROPE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2012-2019 (UNITS)
Table 46 GERMANY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 47 GERMANY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 48 GERMANY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 49 GERMANY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 50 FRANCE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 51 FRANCE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 52 FRANCE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 53 FRANCE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 54 U.K. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 55 U.K. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 56 U.K. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 57 U.K. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 58 ITALY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 59 ITALY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 60 ITALY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 61 ITALY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 62 SPAIN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Table 63 SPAIN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (UNITS)
Table 64 SPAIN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY NUMBER OF INSTALLATIONS/USERS, 2012-2019 (UNITS)
Table 65 SPAIN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY AVERAGE SELLING PRICE (ASP), 2012-2019 (USD)
Table 66 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Table 67 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: MERGERS & ACQUISITIONS
Table 68 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: REGULATORY APPROVALS
Table 69 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: PARTNERSHIP
Table 70 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COLLABORATIONS
Table 71 BAYER HEALTHCARE AG: KEY FINANCIALS, 2009-2014 (USD MN)
Table 72 TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY FINANCIALS, 2011-2014 (USD MN)
Table 73 ACTAVIS PLC: KEY FINANCIALS, 2012-2014 (USD MN)
LIST OF FIGURES
Figure 1 EVOLUTION OF INTRAUTERINE CONTRACEPTIVE DEVICES (IUD/IUCD)
Figure 2 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: SEGMENTATION & COVERAGE
Figure 3 INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: INTEGRATED ECOSYSTEM
Figure 4 TOP-DOWN APPROACH
Figure 5 BOTTOM-UP APPROACH
Figure 6 MACROINDICATOR-BASED APPROACH
Figure 7 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: SNAPSHOT, 2014 (%)
Figure 8 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: GROWTH ANALYSIS, 2014 & 2019
Figure 9 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2014 (USD MN)
Figure 10 ADVERSE EFFECTS CAUSED BY MIRENA, U.S., 1997-2012
Figure 11 GEOGRAPHIC USAGE OF SKYLA
Figure 12 DISCONTINUATION RATES OF SKYLA
Figure 13 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2014 & 2019 (USD MN)
Figure 14 GLOBAL HORMONAL IUCD MARKET, BY GEOGRAPHY, 2012 - 2019
Figure 15 GLOBAL COPPER IUCD MARKET, BY GEOGRAPHY, 2012-2019
Figure 16 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2014 & 2019 (USD MN)
Figure 17 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET OVERVIEW, 2014 & 2019 (USD MN)
Figure 18 ASIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2014 & 2019 (USD MN)
Figure 19 ASIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2014 & 2019 (UNITS)
Figure 20 CHINA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Figure 21 REPUBLIC OF KOREA (ROK) INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Figure 22 JAPAN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019, (USD MN)
Figure 23 INDIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019, (USD MN)
Figure 24 NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2014 & 2019 (USD MN)
Figure 25 NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2014 & 2019 (UNITS)
Figure 26 U.S. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019, (USD MN)
Figure 27 MEXICO INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Figure 28 CANADA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019, (USD MN)
Figure 29 EUROPE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2014 & 2019 (USD MN)
Figure 30 EUROPE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2014 & 2019 (UNITS)
Figure 31 GERMANY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Figure 32 FRANCE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019, (USD MN)
Figure 33 U.K. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019, (USD MN)
Figure 34 ITALY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Figure 35 SPAIN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Figure 36 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Figure 37 BAYER HEALTHCARE AG: REVENUE MIX, 2014 (%)
Figure 38 CONTRIBUTION OF PHARMACEUTICALS SEGMENT TOWARDS COMPANY REVENUE, 2008-2014 (USD MN)
Figure 39 TEVA PHARMACEUTICAL INDUSTRIES LTD.: REVENUE MIX, 2014 (%)
Figure 40 ACTAVIS PLC: REVENUE MIX, 2014 (%)
Figure 1 EVOLUTION OF INTRAUTERINE CONTRACEPTIVE DEVICES (IUD/IUCD)
Figure 2 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: SEGMENTATION & COVERAGE
Figure 3 INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: INTEGRATED ECOSYSTEM
Figure 4 TOP-DOWN APPROACH
Figure 5 BOTTOM-UP APPROACH
Figure 6 MACROINDICATOR-BASED APPROACH
Figure 7 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: SNAPSHOT, 2014 (%)
Figure 8 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: GROWTH ANALYSIS, 2014 & 2019
Figure 9 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2014 (USD MN)
Figure 10 ADVERSE EFFECTS CAUSED BY MIRENA, U.S., 1997-2012
Figure 11 GEOGRAPHIC USAGE OF SKYLA
Figure 12 DISCONTINUATION RATES OF SKYLA
Figure 13 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2014 & 2019 (USD MN)
Figure 14 GLOBAL HORMONAL IUCD MARKET, BY GEOGRAPHY, 2012 - 2019
Figure 15 GLOBAL COPPER IUCD MARKET, BY GEOGRAPHY, 2012-2019
Figure 16 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2014 & 2019 (USD MN)
Figure 17 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET OVERVIEW, 2014 & 2019 (USD MN)
Figure 18 ASIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2014 & 2019 (USD MN)
Figure 19 ASIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2014 & 2019 (UNITS)
Figure 20 CHINA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Figure 21 REPUBLIC OF KOREA (ROK) INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Figure 22 JAPAN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019, (USD MN)
Figure 23 INDIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019, (USD MN)
Figure 24 NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2014 & 2019 (USD MN)
Figure 25 NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2014 & 2019 (UNITS)
Figure 26 U.S. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019, (USD MN)
Figure 27 MEXICO INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Figure 28 CANADA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019, (USD MN)
Figure 29 EUROPE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2014 & 2019 (USD MN)
Figure 30 EUROPE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2014 & 2019 (UNITS)
Figure 31 GERMANY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Figure 32 FRANCE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019, (USD MN)
Figure 33 U.K. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019, (USD MN)
Figure 34 ITALY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Figure 35 SPAIN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012-2019 (USD MN)
Figure 36 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Figure 37 BAYER HEALTHCARE AG: REVENUE MIX, 2014 (%)
Figure 38 CONTRIBUTION OF PHARMACEUTICALS SEGMENT TOWARDS COMPANY REVENUE, 2008-2014 (USD MN)
Figure 39 TEVA PHARMACEUTICAL INDUSTRIES LTD.: REVENUE MIX, 2014 (%)
Figure 40 ACTAVIS PLC: REVENUE MIX, 2014 (%)
